spacer
home > ict > winter 2018 > at the crossroads of healthcare
PUBLICATIONS
International Clinical Trials

At the Crossroads of Healthcare

ICT: What can attendees expect to experience at DIA Europe 2018?

DIA: An energy of innovation, comradery, and openness to new collaborative conversations. Attendees will connect with thought leaders, colleagues, and global professionals across all fields of healthcare and drug development: clinical research, patient advocacy, regulatory affairs, data management, and more. For the past 30 years, DIA’s flagship European conference has been the event to stay tuned into the paths forward and where professionals collaborate on how to overcome their own business challenges. DIA Europe became the annual ‘must-attend’ for many of our members, and this year will be no exception!

For clinical professionals, this will be a chance to gain both a detailed perspective on how clinical trials need to be adapted for the new future, as well as a broader perspective on issues affecting the complete value chain of development. During an intense and stimulating three days, you will learn, debate, and grow.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Carlsbad, CA, 10th January 2023 - Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the life sciences, molecular diagnostics, and biopharma industries, today announced a capital investment led by majority shareholder Telegraph Hill Partners that will be focused on expansion at their Carlsbad, CA, manufacturing facilities.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement